Evidence map›Paper›PMID 42670485›Full record

ArticleHPB cancer international2026

Cutaneous Metastases of Gallbladder Adenocarcinoma Following Percutaneous Cholecystostomy Tube.

Kathryn Cavallo, Corbin Morris, Jonathan M Hernandez

Abstract read
In one paragraph

Article in HPB cancer international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Kathryn CavalloNational Cancer Institute at the National Institutes of Health, Bethesda, MD.ORCID 0000-0001-9903-6684
Corbin MorrisNational Cancer Institute at the National Institutes of Health, Bethesda, MD.
Jonathan M HernandezNational Cancer Institute at the National Institutes of Health, Bethesda, MD.

Funding

Evaluating outcomes for patients with primary-metastatic gastrointestinal cancerZIABC011861 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI HERNANDEZ, JONATHAN · 2019 to 2025
$166k
Intramural NIH HHS ZIA BC011861
6 · The paper itself

Abstract

Gallbladder carcinoma is a rare malignancy with a poor prognosis and is frequently metastatic at the time of diagnosis. Port site or incisional metastases are relatively well documented, and known risk when removing specimens, especially in the setting of incidentally identified gallbladder malignancy. Skin metastasis from a percutaneous cholecystostomy tube placement, have not been well-documented in the literature to date. Here, we report a case of an elderly patient with acute cholecystitis who received a percutaneous cholecystostomy tube and was found to have gallbladder adenocarcinoma following interval cholecystectomy. Post-operatively, he developed a raised lesion at the site of his percutaneous cholecystostomy tube which was biopsied and found to be adenocarcinoma.

Indexed as

cholecystectomycholecystitisGallbladder carcinomapercutaneous cholecystostomy tubeskin metastases

Identifiers

PMID42670485
PMCPMC13526272

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.